Schiffrin Barroway Topaz & Kessler, LLP Announces Court Ruling Relating to Merck...

Schiffrin Barroway Topaz & Kessler, LLP Announces Court Ruling Relating to
Merck & Co. Inc.'s Employee Savings & Security Plan, the Merck & Co., Inc.
Employee Stock Purchase & Savings Plan, and the Merck Puerto Rico Employee
Savings & Security Plan

RADNOR, Pa., June 19 /PRNewswire/ -- ADVERTISEMENT - The following
statement was issued today by the law firm of Schiffrin Barroway Topaz &
Kessler, LLP:
Schiffrin Barroway Topaz & Kessler, LLP is Co-Lead Counsel for the ERISA
plaintiffs in the In re Merck & Co. Inc. Securities, Derivative, & ERISA
Litigation, MDL No. 1658, pending in the U.S. District Court for the District
of New Jersey. The Court recently ruled that claims for violations of the
Employee Retirement Income Security Act of 1974 ("ERISA") relating to the
failure of Merck & Co. Inc. ("Merck" or the "Company") (NYSE: MRK) to disclose
material facts relating to Vytorin cannot be pursued as part of the ERISA
action dealing with issues relating to Vioxx and should be pursued in a
separate case. To date, lawsuits have been filed that allege that the
investments in the Merck Common Stock Fund within the Merck & Co., Inc.
Employee Savings & Security Plan, the Merck & Co., Inc. Employee Stock
Purchase & Savings Plan, or the Merck Puerto Rico Employee Savings & Security
Plan (collectively, the "Merck Plans") have declined substantially because
Merck breached its fiduciary duties to participates of the Merck Plans when it
failed to disclose material facts regarding Vytorin.
If you wish to discuss this action or have any questions concerning this
notice or your rights or interests with respect to these matters and are or
were a participant in the Merck & Co., Inc. Employee Savings & Security Plan,
the Merck & Co., Inc. Employee Stock Purchase & Savings Plan, or the Merck
Puerto Rico Employee Savings & Security Plan during the class period of April
1, 2006 through March 31, 2008, and were invested in the Merck Common Stock
Fund, please contact Schiffrin Barroway Topaz & Kessler, LLP (Edward Ciolko,
Esq. or Tiffany Melvin) toll free at 1-888-299-7706 or 1-610-667-7706, or via
e-mail at info@sbtklaw.com.
Specifically, the new suits allege that Merck breached its fiduciary
duties under ERISA by failing to disclose to participants of the Merck Plans
that the results of the ENHANCE trial showed no statistically significant
difference between patient use of Vytorin versus patients treated with
Simvastatin. When the results of ENHANCE trial of Vytorin were made public on
March 28, 2008 both the Merck Plans and the Merck Plans' participants and
beneficiaries suffered significant losses as Merck's stock price and the value
of the Merck Common Stock Fund in the Merck Plans drastically decreased.
Additionally, the new suits allege that Merck breached its fiduciary duties to
prudently and loyally invest and maintain the assets of the Merck Plans and
provide adequate information to the participants of those Merck Plans through
its actions and omissions, including but not limited to its conduct in
relation to Vytorin.
Schiffrin Barroway Topaz & Kessler, LLP is one of America's leading law
firms handling ERISA retirement plan litigation. We are committed to helping
employees and retirees protect their retirement savings.
If you are a member of the class, you may retain Schiffrin Barroway Topaz
& Kessler, LLP, you may retain other counsel, do nothing, or take other steps
to protect your rights.
Before making your choice of attorney, you should give this matter careful
thought. The selection of an attorney is an important decision. For more
information about Schiffrin Barroway Topaz & Kessler please visit
www.sbtklaw.com.
CONTACT: Schiffrin Barroway Topaz & Kessler, LLP
Edward Ciolko, Esquire
Tiffany Melvin
280 King of Prussia Road
Radnor, PA 19087
1-888-299-7706 (toll free) or 1-610-667-7706
Or by e-mail at info@sbtklaw.com

SOURCE Schiffrin Barroway Topaz & Kessler, LLP

Edward Ciolko, Esquire or Tiffany Melvin of Schiffrin Barroway Topaz &
Kessler, LLP, +1-888-299-7706, or +1-610-667-7706, info@sbtklaw.com